✨ Free AI Report
Pieris Pharmaceuticals, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Pieris Pharmaceuticals, Inc.
Research Preview

Pieris Pharmaceuticals, Inc.: Business Overview, Financials & Competitive Analysis

Pieris Pharmaceuticals is a biotechnology company which discovers and develops Anticalin-based drugs to target validated disease pathways. The company focuses on the development of its 4-1BB bispecifics immuno-oncolog...

Analyst-debate audio for Pieris Pharmaceuticals, Inc.

AskCyborg analysts argue the bull and bear cases for Pieris Pharmaceuticals, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Pieris Pharmaceuticals, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
6/ 10Solid

Cyborg Score thesis

Early-stage biotech with differentiated Anticalin platform and promising 4-1BB bispecific pipeline attracting analyst optimism...

Read the full analyst-debate transcript →
Industry Biotechnology / Immuno-Oncology
2 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 15, 2026
AI-Verified Research
30+ Page Report

Get the Latest Pieris Pharmaceuticals, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Pieris Pharmaceuticals, Inc. Overview

Pro stress-test →

Pieris Pharmaceuticals is a biotechnology company which discovers and develops Anticalin-based drugs to target validated disease pathways. The company focuses on the development of its 4-1BB bispecifics immuno-oncology (IO) programs.

Strategic Profile

Pro stress-test →

The Anticalin platform technology focuses on low molecular-weight Anticalin proteins that can bind tightly and specifically to a diverse range of targets, and is modular, allowing the design of multimeric Anticalin based bi- and multi-specific proteins. The clinical pipeline consists of immuno-oncology programs including S095012, SGN-BB228, and BOS-342 in partnership with collaborators.

Competitive Landscape

Pro stress-test →

Pieris competes in the immuno-oncology bispecific space against larger biotech and pharma companies developing similar technologies. Key competitors include companies developing 4-1BB bispecifics and alternative immuno-oncology approaches.

Industry Context

Pieris Pharmaceuticals, Inc. operates in Biotechnology / Immuno-Oncology.

Key facts

Headquarters: Boston, US

What the analysts stress-tested

The top findings that survived the multi-agent debate for Pieris Pharmaceuticals, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Pieris Pharmaceuticals, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

4-1BB Bispecific ProgramsCo-development partner on CD228 x 4-1BB program→Checkpoint InhibitorsCompeting immuno-oncology therapeutic approaches→

Compare Pieris Pharmaceuticals, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Pieris Pharmaceuticals, Inc. operates in Biotechnology / Immuno-Oncology. See how the rest of the sector scores on the Cyborg framework.

Browse Biotechnology / Immuno-Oncology research →
NEW · MCP server

Ask your AI assistant about Pieris Pharmaceuticals, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Pieris Pharmaceuticals, Inc. and its top competitor on Cyborg Score”
“What did Pieris Pharmaceuticals, Inc. do this quarter?”
“Is Pieris Pharmaceuticals, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Pieris Pharmaceuticals, Inc. do?+
Pieris Pharmaceuticals is a biotechnology company which discovers and develops Anticalin-based drugs to target validated disease pathways. The company focuses on the development of its 4-1BB bispecifics immuno-oncolog...
What is Pieris Pharmaceuticals, Inc.'s Cyborg Score?+
Pieris Pharmaceuticals, Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Pieris Pharmaceuticals, Inc.'s main competitors?+
Named competitors include 4-1BB Bispecific Programs, Checkpoint Inhibitors. The full competitive landscape is in the AskCyborg report.
How can I get the full Pieris Pharmaceuticals, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Pieris Pharmaceuticals, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Pieris Pharmaceuticals, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9National Bank of Pakistan9RENK Group AG9Lumentum Holdings Inc.9First Abu Dhabi Bank9The Travelers Companies, Inc.9BAE Systems plc9Arista Networks9KLA Corporation9Hermès International S.A.8Enerjisa Enerji A.Ş.8Emirates Central Cooling Systems Corporation8WALLIX Group8StealthGas Inc.8SofWave Medical Ltd.8Himalaya Shipping Ltd.8Bannerman Energy Ltd8Sembcorp Salalah Power & Water Company8MilDef Group